Fragmin

Fragmin (Dalteparin Sodium) is a low-molecular-weight heparin used for anticoagulation. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis. This medication helps prevent blood clots in various medical conditions.

Fragmin is primarily used for anticoagulation to prevent blood clots. It is often prescribed for conditions requiring blood thinning, such as during haemodialysis or for patients at risk of deep vein thrombosis. The medication is also used in the management of certain cardiovascular conditions where blood clot prevention is crucial.

Common effects of Fragmin may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions or changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Fragmin should be used with caution in patients with a history of bleeding disorders or recent surgery. Regular monitoring of blood clotting parameters is recommended. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Fragmin may interact with other anticoagulants, antiplatelet drugs, and certain pain medications. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication while using Fragmin.